Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Claritev Corp (CTEV)

Claritev appoints Jennifer Main to board, expanding board to 12 directors

Neutral Impact 2 of 5 leadership Written later

Claritev Corporation increased its board from 11 to 12 directors and appointed Jennifer Main, a former CMS Chief Operating Officer and TARP chief financial officer, to fill the new seat effective October 15, 2026. Main also joined the Audit Committee, replacing Jason Kap on that committee. The filing describes a board addition rather than a change in financial results or guidance.

Key points

  • Board increased from 11 to 12 directors; Jennifer Main appointed as Class II director effective October 15, 2026
  • Main joins the Audit Committee; Jason Kap ceased serving on the Audit Committee
  • Main previously served as Chief Operating Officer of CMS from 2018 to 2021 and as Chief Financial Officer of Amalgam Rx from 2021 to 2026
  • Main will receive non-employee director compensation under the company's existing policy and sign the standard indemnification agreement

The filing

CompanyClaritev Corp (CTEV)
Form8-K, current report
Filed with the SECOct 15, 2026, 9:03 AM ET
Accession number0001793229-26-000077

Items reported: 5.02 Director / Officer Change7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:43 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 15, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.